Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitor
Authors:
Open Access
- 3 January 2017
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 39662
Abstract
Pain places a devastating burden on patients and society and current pain therapeutics exhibit limitations in efficacy, unwanted side effects and the potential for drug abuse and diversion. Although genetic evidence has clearly demonstrated that the voltage-gated sodium channel, Nav1.7, is critical to pain sensation in mammals, pharmacological inhibitors of Nav1.7 have not yet fully recapitulated the dramatic analgesia observed in Nav1.7-null subjects. Using the tarantula venom-peptide ProTX-II as a scaffold, we engineered a library of over 1500 venom-derived peptides and identified JNJ63955918 as a potent, highly selective, closed-state Nav1.7 blocking peptide. Here we show that JNJ63955918 induces a pharmacological insensitivity to pain that closely recapitulates key features of the Nav1.7-null phenotype seen in mice and humans. Our findings demonstrate that a high degree of selectivity, coupled with a closed-state dependent mechanism of action is required for strong efficacy and indicate that peptides such as JNJ63955918 and other suitably optimized Nav1.7 inhibitors may represent viable non-opioid alternatives for the pharmacological treatment of severe pain.Keywords
This publication has 57 references indexed in Scilit:
- Transient opening of the perineurial barrier for analgesic drug deliveryProceedings of the National Academy of Sciences, 2012
- Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neuronsNature Communications, 2012
- Loss-of-function mutations in sodium channel Nav1.7 cause anosmiaNature, 2011
- The Tarantula Toxins ProTx-II and Huwentoxin-IV Differentially Interact with Human Nav1.7 Voltage Sensors to Inhibit Channel Activation and InactivationMolecular Pharmacology, 2010
- Deconstructing voltage sensor function and pharmacology in sodium channelsNature, 2008
- Inflammatory Mediators Increase Nav1.9 Current and Excitability in Nociceptors through a Coincident Detection MechanismJournal of General Physiology, 2008
- A stop codon mutation in SCN9A causes lack of pain sensationHuman Molecular Genetics, 2007
- Molecular Interactions of the Gating Modifier Toxin ProTx-II with Nav1.5Journal of Biological Chemistry, 2007
- SCN9A Mutations in Paroxysmal Extreme Pain Disorder: Allelic Variants Underlie Distinct Channel Defects and PhenotypesNeuron, 2006
- NMRPipe: A multidimensional spectral processing system based on UNIX pipesJournal of Biomolecular NMR, 1995